Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1

Interventions

Exercise 4semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Topiramate 1Tirzepatide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Resistance Training 1Qsymia 1Phentermine 1Naltrexone 1Liraglutide 1Glucagon-Like Peptide-1 Receptor 1Fluorescence Polarization Immunoassay 1Exercise Test 1Echocardiography 1Docosahexaenoic Acids 1Diethylpropion 1Diet, Plant-Based 1Diet 1Counseling 1Caloric Restriction 1Bupropion 1Blood Specimen Collection 1Biopsy 1Adiposity 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Obesity × Qsymia × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡